Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nevro Arendal AS
AS
Active
Org 919909978
Stoaveien 9, 4848
Arendal
General medical practice activities
·
NACE 8621
Est. 2017 · 8 years old
4 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Nevro Arendal AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
15M
11M
7M
4M
0M
2021: 8M
8M
2021
2022: 9M (+13% vs 2021)
9M
+13%
2022
2023: 10M (+11% vs 2022)
10M
+11%
2023
2024: 11M (+10% vs 2023)
11M
+10%
2024
2025: 12M (+9% vs 2024)
12M
+9%
2025
EBITDA
NOK millions
10M
7M
5M
2M
0M
2021: 6M
6M
2021
2022: 6M (0% vs 2021)
6M
0%
2022
2023: 7M (+17% vs 2022)
7M
+17%
2023
2024: 8M (+14% vs 2023)
8M
+14%
2024
2025: 8M (0% vs 2024)
8M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
12 004
10 964
10 305
9 077
8 491
Staff expenses
−2 500
−1 957
−2 605
−2 330
−1 580
EBITDA
8 233
7 968
6 583
5 719
5 922
Depreciation & amort.
−122
−186
−160
−160
−207
EBIT
8 110
7 781
6 423
5 559
5 715
Net financials
42
−15
0
−1
−0
Profit before tax
8 153
7 766
6 423
5 559
5 715
Tax
1 793
1 712
−0
1 234
1 257
Net profit
6 359
6 054
5 010
4 324
4 458
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
12 535
8 776
7 611
6 348
6 258
Equity
8 785
2 425
371
361
566
Long-term debt
64
52
21
29
39
Short-term debt
3 686
6 299
7 219
5 958
5 653
Total debt
3 750
6 351
7 240
5 987
5 692
Financial ratios
5-year trend
EBITDA margin
68,6 %
This company
15,8 %
Market median
This company
Market median
334% above market
2021
2025
Equity ratio
70,1 %
This company
38,2 %
Market median
This company
Market median
84% above market
2021
2025
Return on equity
72,4 %
This company
18,4 %
Market median
This company
Market median
293% above market
2021
2025
Net profit margin
53,0 %
This company
8,1 %
Market median
This company
Market median
554% above market
2021
2025
Asset turnover
0,96×
This company
1,12×
Market median
This company
Market median
14% below market
2021
2025
Debt / equity
0,43×
This company
0,62×
Market median
This company
Market median
31% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nevro Arendal AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
